Cargando…

Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation

INTRODUCTION: Chromosomal microarray analysis (CMA) has currently been considered as the first-tier genetic test for patients with developmental delay/intellectual disability (DD/ID) in many countries. In this study, we performed an extensive assessment of the value of CMA for the diagnosis of child...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ting, Zhang, Zhu, Wang, Jiamin, Li, Qinqin, Zhu, Hongmei, Lai, Yi, Wang, He, Liu, Shanling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875000/
https://www.ncbi.nlm.nih.gov/pubmed/31781653
http://dx.doi.org/10.1155/2019/9352581
_version_ 1783472931847798784
author Hu, Ting
Zhang, Zhu
Wang, Jiamin
Li, Qinqin
Zhu, Hongmei
Lai, Yi
Wang, He
Liu, Shanling
author_facet Hu, Ting
Zhang, Zhu
Wang, Jiamin
Li, Qinqin
Zhu, Hongmei
Lai, Yi
Wang, He
Liu, Shanling
author_sort Hu, Ting
collection PubMed
description INTRODUCTION: Chromosomal microarray analysis (CMA) has currently been considered as the first-tier genetic test for patients with developmental delay/intellectual disability (DD/ID) in many countries. In this study, we performed an extensive assessment of the value of CMA for the diagnosis of children with ID/DD in China. METHODS: A total of 633 patients diagnosed with DD/ID in West China Second University Hospital, Sichuan University, were recruited from January 2014 to March 2019. The patients were classified into 4 subgroups: isolated DD/ID, DD/ID with multiple congenital anomalies (MCA), isolated autism spectrum disorders (ASDs), and DD/ID with epilepsy. CMA was performed on Affymetrix 750K platform. RESULTS: Among the 633 patients, 127 cases were identified as having pathogenic copy number variations (pCNVs) with an overall positive rate of 20.06%. Of the 127 cases with abnormal results, 76 cases had 35 types of microdeletion/microduplication syndromes (59.84%) including 5 cases caused by uniparental disomy (UPD), and 18 cases had unbalanced rearrangements (14.17%) including 10 cases inherited from parental balanced translocations or pericentric inversions. The diagnostic yields of pCNVs for the subgroups of isolated DD/ID, DD/ID with MCA, isolated ASD, and DD/ID with epilepsy were 18.07% (60/332), 34.90% (52/149), 3.70% (3/81), and 16.90% (12/71), respectively. The diagnostic yield of pCNVs in DD/ID patients with MCA was significantly higher than that of the other three subgroups, and the diagnostic yield of pCNVs in isolated ASD patients was significantly lower than that of the other three subgroups (p < 0.05). CONCLUSION: Microdeletion/microduplication syndromes and unbalanced rearrangements are probably the main genetic etiological factors for DD/ID. DD/ID patients with MCA have a higher rate of chromosomal aberrations. Parents of DD/ID children with submicroscopic unbalance rearrangements are more likely to have chromosome balanced translocations or pericentric inversions, which might have been missed by karyotyping. CMA can significantly improve the diagnostic rate for patients with DD/ID, which is of great value for medical management and clinical guidance for genetic counseling.
format Online
Article
Text
id pubmed-6875000
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-68750002019-11-28 Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation Hu, Ting Zhang, Zhu Wang, Jiamin Li, Qinqin Zhu, Hongmei Lai, Yi Wang, He Liu, Shanling Biomed Res Int Research Article INTRODUCTION: Chromosomal microarray analysis (CMA) has currently been considered as the first-tier genetic test for patients with developmental delay/intellectual disability (DD/ID) in many countries. In this study, we performed an extensive assessment of the value of CMA for the diagnosis of children with ID/DD in China. METHODS: A total of 633 patients diagnosed with DD/ID in West China Second University Hospital, Sichuan University, were recruited from January 2014 to March 2019. The patients were classified into 4 subgroups: isolated DD/ID, DD/ID with multiple congenital anomalies (MCA), isolated autism spectrum disorders (ASDs), and DD/ID with epilepsy. CMA was performed on Affymetrix 750K platform. RESULTS: Among the 633 patients, 127 cases were identified as having pathogenic copy number variations (pCNVs) with an overall positive rate of 20.06%. Of the 127 cases with abnormal results, 76 cases had 35 types of microdeletion/microduplication syndromes (59.84%) including 5 cases caused by uniparental disomy (UPD), and 18 cases had unbalanced rearrangements (14.17%) including 10 cases inherited from parental balanced translocations or pericentric inversions. The diagnostic yields of pCNVs for the subgroups of isolated DD/ID, DD/ID with MCA, isolated ASD, and DD/ID with epilepsy were 18.07% (60/332), 34.90% (52/149), 3.70% (3/81), and 16.90% (12/71), respectively. The diagnostic yield of pCNVs in DD/ID patients with MCA was significantly higher than that of the other three subgroups, and the diagnostic yield of pCNVs in isolated ASD patients was significantly lower than that of the other three subgroups (p < 0.05). CONCLUSION: Microdeletion/microduplication syndromes and unbalanced rearrangements are probably the main genetic etiological factors for DD/ID. DD/ID patients with MCA have a higher rate of chromosomal aberrations. Parents of DD/ID children with submicroscopic unbalance rearrangements are more likely to have chromosome balanced translocations or pericentric inversions, which might have been missed by karyotyping. CMA can significantly improve the diagnostic rate for patients with DD/ID, which is of great value for medical management and clinical guidance for genetic counseling. Hindawi 2019-11-06 /pmc/articles/PMC6875000/ /pubmed/31781653 http://dx.doi.org/10.1155/2019/9352581 Text en Copyright © 2019 Ting Hu et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hu, Ting
Zhang, Zhu
Wang, Jiamin
Li, Qinqin
Zhu, Hongmei
Lai, Yi
Wang, He
Liu, Shanling
Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation
title Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation
title_full Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation
title_fullStr Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation
title_full_unstemmed Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation
title_short Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation
title_sort chromosomal aberrations in pediatric patients with developmental delay/intellectual disability: a single-center clinical investigation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875000/
https://www.ncbi.nlm.nih.gov/pubmed/31781653
http://dx.doi.org/10.1155/2019/9352581
work_keys_str_mv AT huting chromosomalaberrationsinpediatricpatientswithdevelopmentaldelayintellectualdisabilityasinglecenterclinicalinvestigation
AT zhangzhu chromosomalaberrationsinpediatricpatientswithdevelopmentaldelayintellectualdisabilityasinglecenterclinicalinvestigation
AT wangjiamin chromosomalaberrationsinpediatricpatientswithdevelopmentaldelayintellectualdisabilityasinglecenterclinicalinvestigation
AT liqinqin chromosomalaberrationsinpediatricpatientswithdevelopmentaldelayintellectualdisabilityasinglecenterclinicalinvestigation
AT zhuhongmei chromosomalaberrationsinpediatricpatientswithdevelopmentaldelayintellectualdisabilityasinglecenterclinicalinvestigation
AT laiyi chromosomalaberrationsinpediatricpatientswithdevelopmentaldelayintellectualdisabilityasinglecenterclinicalinvestigation
AT wanghe chromosomalaberrationsinpediatricpatientswithdevelopmentaldelayintellectualdisabilityasinglecenterclinicalinvestigation
AT liushanling chromosomalaberrationsinpediatricpatientswithdevelopmentaldelayintellectualdisabilityasinglecenterclinicalinvestigation